Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9973 to 9984 of 12569 entries
Sorted by: Best Match Show Resources per page
[No title available]

Frontiers in pharmacology

Bonaterra GA, Mierau O, Hofmann J, Schwarzbach H, Aziz-Kalbhenn H, Kolb C, Kinscherf R.
PMID: 33628177
Front Pharmacol. 2020 Dec 03;11:603575. doi: 10.3389/fphar.2020.603575. eCollection 2020.

No abstract available.

Cite
Bonaterra GA, Mierau O, Hofmann J, et al. . Front Pharmacol. 2020;11:603575doi: 10.3389/fphar.2020.603575.
Bonaterra, G. A., Mierau, O., Hofmann, J., Schwarzbach, H., Aziz-Kalbhenn, H., Kolb, C., & Kinscherf, R. (2020). . Frontiers in pharmacology, 11603575. https://doi.org/10.3389/fphar.2020.603575
Bonaterra, Gabriel A, et al. "." Frontiers in pharmacology vol. 11 (2020): 603575. doi: https://doi.org/10.3389/fphar.2020.603575
Bonaterra GA, Mierau O, Hofmann J, Schwarzbach H, Aziz-Kalbhenn H, Kolb C, Kinscherf R. . Front Pharmacol. 2020 Dec 03;11:603575. doi: 10.3389/fphar.2020.603575. eCollection 2020. PMID: 33628177; PMCID: PMC7898673.
Copy Download .nbib Format: NLM
An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer.

Frontiers in pharmacology

Yang B, Yang N, Chen Y, Zhu M, Lian Y, Xiong Z, Wang B, Feng L, Jia X.
PMID: 33628171
Front Pharmacol. 2021 Jan 14;11:580978. doi: 10.3389/fphar.2020.580978. eCollection 2020.

Lung cancer is one of the most devastating diseases worldwide, with high incidence and mortality worldwide, and the anticancer potential of traditional Chinese medicine (TCM) has been gradually recognized by the scientific community. Astragali Radix (AR) is commonly used...

Cite
Yang B, Yang N, Chen Y, et al. An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer. Front Pharmacol. 2021;11:580978doi: 10.3389/fphar.2020.580978.
Yang, B., Yang, N., Chen, Y., Zhu, M., Lian, Y., Xiong, Z., Wang, B., Feng, L., & Jia, X. (2020). An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer. Frontiers in pharmacology, 11580978. https://doi.org/10.3389/fphar.2020.580978
Yang, Bing, et al. "An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer." Frontiers in pharmacology vol. 11 (2020): 580978. doi: https://doi.org/10.3389/fphar.2020.580978
Yang B, Yang N, Chen Y, Zhu M, Lian Y, Xiong Z, Wang B, Feng L, Jia X. An Integrated Strategy for Effective-Component Discovery of Astragali Radix in the Treatment of Lung Cancer. Front Pharmacol. 2021 Jan 14;11:580978. doi: 10.3389/fphar.2020.580978. eCollection 2020. PMID: 33628171; PMCID: PMC7898675.
Copy Download .nbib Format: NLM
Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications.

Frontiers in pharmacology

Sefah IA, Ogunleye OO, Essah DO, Opanga SA, Butt N, Wamaitha A, Guantai AN, Chikowe I, Khuluza F, Kibuule D, Nambahu L, Abubakar AR, Sani IH, Saleem Z, Kalungia AC, Thi Phuong TN, Haque M, Islam S, Kumar S, Sneddon J, Wamboga J, Wale J, Miljković N, Kurdi A, Martin AP, Godman B.
PMID: 33628173
Front Pharmacol. 2021 Jan 14;11:588106. doi: 10.3389/fphar.2020.588106. eCollection 2020.

No abstract available.

Cite
Sefah IA, Ogunleye OO, Essah DO, et al. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front Pharmacol. 2021;11:588106doi: 10.3389/fphar.2020.588106.
Sefah, I. A., Ogunleye, O. O., Essah, D. O., Opanga, S. A., Butt, N., Wamaitha, A., Guantai, A. N., Chikowe, I., Khuluza, F., Kibuule, D., Nambahu, L., Abubakar, A. R., Sani, I. H., Saleem, Z., Kalungia, A. C., Thi Phuong, T. N., Haque, M., Islam, S., Kumar, S., Sneddon, J., Wamboga, J., Wale, J., Miljković, N., Kurdi, A., Martin, A. P., & Godman, B. (2020). Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Frontiers in pharmacology, 11588106. https://doi.org/10.3389/fphar.2020.588106
Sefah, Israel Abebrese, et al. "Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications." Frontiers in pharmacology vol. 11 (2020): 588106. doi: https://doi.org/10.3389/fphar.2020.588106
Sefah IA, Ogunleye OO, Essah DO, Opanga SA, Butt N, Wamaitha A, Guantai AN, Chikowe I, Khuluza F, Kibuule D, Nambahu L, Abubakar AR, Sani IH, Saleem Z, Kalungia AC, Thi Phuong TN, Haque M, Islam S, Kumar S, Sneddon J, Wamboga J, Wale J, Miljković N, Kurdi A, Martin AP, Godman B. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications. Front Pharmacol. 2021 Jan 14;11:588106. doi: 10.3389/fphar.2020.588106. eCollection 2020. PMID: 33628173; PMCID: PMC7898676.
Copy Download .nbib Format: NLM
Antibacterial Activities of .

Frontiers in pharmacology

Deyno S, Mtewa AG, Hope D, Bazira J, Makonnen E, Alele PE.
PMID: 33597879
Front Pharmacol. 2021 Jan 25;11:608672. doi: 10.3389/fphar.2020.608672. eCollection 2020.

No abstract available.

Cite
Deyno S, Mtewa AG, Hope D, et al. Antibacterial Activities of . Front Pharmacol. 2021;11:608672doi: 10.3389/fphar.2020.608672.
Deyno, S., Mtewa, A. G., Hope, D., Bazira, J., Makonnen, E., & Alele, P. E. (2020). Antibacterial Activities of . Frontiers in pharmacology, 11608672. https://doi.org/10.3389/fphar.2020.608672
Deyno, Serawit, et al. "Antibacterial Activities of ." Frontiers in pharmacology vol. 11 (2020): 608672. doi: https://doi.org/10.3389/fphar.2020.608672
Deyno S, Mtewa AG, Hope D, Bazira J, Makonnen E, Alele PE. Antibacterial Activities of . Front Pharmacol. 2021 Jan 25;11:608672. doi: 10.3389/fphar.2020.608672. eCollection 2020. PMID: 33597879; PMCID: PMC7883827.
Copy Download .nbib Format: NLM
Tanshinone IIA: A Review of its Anticancer Effects.

Frontiers in pharmacology

Fang ZY, Zhang M, Liu JN, Zhao X, Zhang YQ, Fang L.
PMID: 33597880
Front Pharmacol. 2021 Jan 14;11:611087. doi: 10.3389/fphar.2020.611087. eCollection 2020.

Tanshinone IIA (Tan IIA) is a pharmacologically lipophilic active constituent isolated from the roots and rhizomes of the Chinese medicinal herb

Cite
Fang ZY, Zhang M, Liu JN, et al. Tanshinone IIA: A Review of its Anticancer Effects. Front Pharmacol. 2021;11:611087doi: 10.3389/fphar.2020.611087.
Fang, Z. Y., Zhang, M., Liu, J. N., Zhao, X., Zhang, Y. Q., & Fang, L. (2020). Tanshinone IIA: A Review of its Anticancer Effects. Frontiers in pharmacology, 11611087. https://doi.org/10.3389/fphar.2020.611087
Fang, Zhong-Ying, et al. "Tanshinone IIA: A Review of its Anticancer Effects." Frontiers in pharmacology vol. 11 (2020): 611087. doi: https://doi.org/10.3389/fphar.2020.611087
Fang ZY, Zhang M, Liu JN, Zhao X, Zhang YQ, Fang L. Tanshinone IIA: A Review of its Anticancer Effects. Front Pharmacol. 2021 Jan 14;11:611087. doi: 10.3389/fphar.2020.611087. eCollection 2020. PMID: 33597880; PMCID: PMC7883641.
Copy Download .nbib Format: NLM
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System.

Frontiers in pharmacology

De Caro C, Cristiano C, Avagliano C, Cuozzo M, La Rana G, Aviello G, De Sarro G, Calignano A, Russo E, Russo R.
PMID: 33597883
Front Pharmacol. 2021 Feb 01;11:620221. doi: 10.3389/fphar.2020.620221. eCollection 2020.

Pain conditions, such as neuropathic pain (NP) and persistent inflammatory pain are therapeutically difficult to manage. Previous studies have shown the involvement of glutamate receptor in pain modulation and in particular same of these showed the key role of...

Cite
De Caro C, Cristiano C, Avagliano C, et al. Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System. Front Pharmacol. 2021;11:620221doi: 10.3389/fphar.2020.620221.
De Caro, C., Cristiano, C., Avagliano, C., Cuozzo, M., La Rana, G., Aviello, G., De Sarro, G., Calignano, A., Russo, E., & Russo, R. (2020). Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System. Frontiers in pharmacology, 11620221. https://doi.org/10.3389/fphar.2020.620221
De Caro, Carmen, et al. "Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System." Frontiers in pharmacology vol. 11 (2020): 620221. doi: https://doi.org/10.3389/fphar.2020.620221
De Caro C, Cristiano C, Avagliano C, Cuozzo M, La Rana G, Aviello G, De Sarro G, Calignano A, Russo E, Russo R. Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System. Front Pharmacol. 2021 Feb 01;11:620221. doi: 10.3389/fphar.2020.620221. eCollection 2020. PMID: 33597883; PMCID: PMC7883473.
Copy Download .nbib Format: NLM
Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Frontiers in pharmacology

Zheng Q, Wang Y, Yang H, Sun L, Fu X, Wei R, Liu YN, Liu WJ.
PMID: 33597868
Front Pharmacol. 2021 Jan 12;11:573645. doi: 10.3389/fphar.2020.573645. eCollection 2020.

No abstract available.

Cite
Zheng Q, Wang Y, Yang H, et al. Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Front Pharmacol. 2021;11:573645doi: 10.3389/fphar.2020.573645.
Zheng, Q., Wang, Y., Yang, H., Sun, L., Fu, X., Wei, R., Liu, Y. N., & Liu, W. J. (2020). Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Frontiers in pharmacology, 11573645. https://doi.org/10.3389/fphar.2020.573645
Zheng, Qiyan, et al. "Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis." Frontiers in pharmacology vol. 11 (2020): 573645. doi: https://doi.org/10.3389/fphar.2020.573645
Zheng Q, Wang Y, Yang H, Sun L, Fu X, Wei R, Liu YN, Liu WJ. Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Front Pharmacol. 2021 Jan 12;11:573645. doi: 10.3389/fphar.2020.573645. eCollection 2020. PMID: 33597868; PMCID: PMC7883598.
Copy Download .nbib Format: NLM
Combination Effect of Three Main Constituents From .

Frontiers in pharmacology

Liu CP, Liu JX, Gu J, Liu F, Li JH, Bin-Yang, Yuan-Zheng, Jie-Li, Wu SH, Wu QH, Xian-Zhang, Li LM, Yang HL, Wang L, Li X.
PMID: 33597870
Front Pharmacol. 2021 Jan 11;11:580064. doi: 10.3389/fphar.2020.580064. eCollection 2020.

Caffeoylquinic acids, coumarins and dicaffeoyl derivatives are considered to be three kinds of the most abundant bioactive components in

Cite
Liu CP, Liu JX, Gu J, et al. Combination Effect of Three Main Constituents From . Front Pharmacol. 2021;11:580064doi: 10.3389/fphar.2020.580064.
Liu, C. P., Liu, J. X., Gu, J., Liu, F., Li, J. H., Bin-Yang, Yuan-Zheng, Jie-Li, Wu, S. H., Wu, Q. H., Xian-Zhang, Li, L. M., Yang, H. L., Wang, L., & Li, X. (2020). Combination Effect of Three Main Constituents From . Frontiers in pharmacology, 11580064. https://doi.org/10.3389/fphar.2020.580064
Liu, Chun-Ping, et al. "Combination Effect of Three Main Constituents From ." Frontiers in pharmacology vol. 11 (2020): 580064. doi: https://doi.org/10.3389/fphar.2020.580064
Liu CP, Liu JX, Gu J, Liu F, Li JH, Bin-Yang, Yuan-Zheng, Jie-Li, Wu SH, Wu QH, Xian-Zhang, Li LM, Yang HL, Wang L, Li X. Combination Effect of Three Main Constituents From . Front Pharmacol. 2021 Jan 11;11:580064. doi: 10.3389/fphar.2020.580064. eCollection 2020. PMID: 33597870; PMCID: PMC7883675.
Copy Download .nbib Format: NLM
Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice.

Frontiers in pharmacology

Zhang J, Hong Y, Xie P, Chen Y, Jiang L, Yang Z, Cao G, Chen Z, Liu X, Chen Y, Wu Y, Cai Z.
PMID: 33597874
Front Pharmacol. 2021 Jan 12;11:593815. doi: 10.3389/fphar.2020.593815. eCollection 2020.

Bufalin (BFL) and cinobufagin (CBF) are the principal bioactive constituents of Chansu, a widely used traditional Chinese medicine (TCM). The synergistic effects of potential active components are responsible for the bioactivities of TCM. Our results showed that the cotreatment...

Cite
Zhang J, Hong Y, Xie P, et al. Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice. Front Pharmacol. 2021;11:593815doi: 10.3389/fphar.2020.593815.
Zhang, J., Hong, Y., Xie, P., Chen, Y., Jiang, L., Yang, Z., Cao, G., Chen, Z., Liu, X., Chen, Y., Wu, Y., & Cai, Z. (2020). Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice. Frontiers in pharmacology, 11593815. https://doi.org/10.3389/fphar.2020.593815
Zhang, Jinghui, et al. "Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice." Frontiers in pharmacology vol. 11 (2020): 593815. doi: https://doi.org/10.3389/fphar.2020.593815
Zhang J, Hong Y, Xie P, Chen Y, Jiang L, Yang Z, Cao G, Chen Z, Liu X, Chen Y, Wu Y, Cai Z. Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice. Front Pharmacol. 2021 Jan 12;11:593815. doi: 10.3389/fphar.2020.593815. eCollection 2020. PMID: 33597874; PMCID: PMC7883642.
Copy Download .nbib Format: NLM
An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.

Frontiers in pharmacology

Copaescu A, Gibson A, Li Y, Trubiano JA, Phillips EJ.
PMID: 33597867
Front Pharmacol. 2021 Jan 12;11:573573. doi: 10.3389/fphar.2020.573573. eCollection 2020.

Delayed drug hypersensitivity reactions are clinically diverse reactions that vary from isolated benign skin conditions that remit quickly with no or symptomatic treatment, drug discontinuation or even continued drug treatment, to the other extreme of severe cutaneous adverse reactions...

Cite
Copaescu A, Gibson A, Li Y, et al. An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity. Front Pharmacol. 2021;11:573573doi: 10.3389/fphar.2020.573573.
Copaescu, A., Gibson, A., Li, Y., Trubiano, J. A., & Phillips, E. J. (2020). An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity. Frontiers in pharmacology, 11573573. https://doi.org/10.3389/fphar.2020.573573
Copaescu, Ana, et al. "An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity." Frontiers in pharmacology vol. 11 (2020): 573573. doi: https://doi.org/10.3389/fphar.2020.573573
Copaescu A, Gibson A, Li Y, Trubiano JA, Phillips EJ. An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity. Front Pharmacol. 2021 Jan 12;11:573573. doi: 10.3389/fphar.2020.573573. eCollection 2020. PMID: 33597867; PMCID: PMC7883592.
Copy Download .nbib Format: NLM
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region.

Frontiers in pharmacology

Burato S, Leonardi L, Antonazzo IC, Raschi E, Ajolfi C, Baraghini M, Chiarello A, Delmonte V, Di Castri L, Donati M, Fadda A, Fedele D, Ferretti A, Gabrielli L, Gobbi S, Lughi S, Mazzari M, Pieraccini F, Renzetti A, Russi E, Scanelli C, Zanetti B, Poluzzi E.
PMID: 33628186
Front Pharmacol. 2021 Feb 11;11:624888. doi: 10.3389/fphar.2020.624888. eCollection 2020.

No abstract available.

Cite
Burato S, Leonardi L, Antonazzo IC, et al. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region. Front Pharmacol. 2021;11:624888doi: 10.3389/fphar.2020.624888.
Burato, S., Leonardi, L., Antonazzo, I. C., Raschi, E., Ajolfi, C., Baraghini, M., Chiarello, A., Delmonte, V., Di Castri, L., Donati, M., Fadda, A., Fedele, D., Ferretti, A., Gabrielli, L., Gobbi, S., Lughi, S., Mazzari, M., Pieraccini, F., Renzetti, A., Russi, E., Scanelli, C., Zanetti, B., & Poluzzi, E. (2020). Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region. Frontiers in pharmacology, 11624888. https://doi.org/10.3389/fphar.2020.624888
Burato, Sofia, et al. "Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region." Frontiers in pharmacology vol. 11 (2020): 624888. doi: https://doi.org/10.3389/fphar.2020.624888
Burato S, Leonardi L, Antonazzo IC, Raschi E, Ajolfi C, Baraghini M, Chiarello A, Delmonte V, Di Castri L, Donati M, Fadda A, Fedele D, Ferretti A, Gabrielli L, Gobbi S, Lughi S, Mazzari M, Pieraccini F, Renzetti A, Russi E, Scanelli C, Zanetti B, Poluzzi E. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region. Front Pharmacol. 2021 Feb 11;11:624888. doi: 10.3389/fphar.2020.624888. eCollection 2020. PMID: 33628186; PMCID: PMC7898059.
Copy Download .nbib Format: NLM
DNA Repair Pathways in Cancer Therapy and Resistance.

Frontiers in pharmacology

Li LY, Guan YD, Chen XS, Yang JM, Cheng Y.
PMID: 33628188
Front Pharmacol. 2021 Feb 08;11:629266. doi: 10.3389/fphar.2020.629266. eCollection 2020.

DNA repair pathways are triggered to maintain genetic stability and integrity when mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The deregulation of DNA repair pathways is associated with the initiation and progression of cancer. As the...

Cite
Li LY, Guan YD, Chen XS, et al. DNA Repair Pathways in Cancer Therapy and Resistance. Front Pharmacol. 2021;11:629266doi: 10.3389/fphar.2020.629266.
Li, L. Y., Guan, Y. D., Chen, X. S., Yang, J. M., & Cheng, Y. (2020). DNA Repair Pathways in Cancer Therapy and Resistance. Frontiers in pharmacology, 11629266. https://doi.org/10.3389/fphar.2020.629266
Li, Lan-Ya, et al. "DNA Repair Pathways in Cancer Therapy and Resistance." Frontiers in pharmacology vol. 11 (2020): 629266. doi: https://doi.org/10.3389/fphar.2020.629266
Li LY, Guan YD, Chen XS, Yang JM, Cheng Y. DNA Repair Pathways in Cancer Therapy and Resistance. Front Pharmacol. 2021 Feb 08;11:629266. doi: 10.3389/fphar.2020.629266. eCollection 2020. PMID: 33628188; PMCID: PMC7898236.
Copy Download .nbib Format: NLM
Showing 9973 to 9984 of 12569 entries